Cargando…

Pulmonary Hypertension due to Lung Diseases and/or Hypoxia: What Do We Actually Know?

Detalles Bibliográficos
Autores principales:	Kosanovic, Djuro, Herrera, Emilio A., Sydykov, Akylbek, Orfanos, Stylianos E., El Agha, Elie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592404/ https://www.ncbi.nlm.nih.gov/pubmed/28932130 http://dx.doi.org/10.1155/2017/9598089

Ejemplares similares

Is fever good? What do we actually know?
por: Rhodes, Jonathan KJ
Publicado: (2015)

Influence of gender in monocrotaline and chronic hypoxia induced pulmonary hypertension in obese rats and mice
por: Neupane, Balram, et al.
Publicado: (2020)

Yarsagumba is a Promising Therapeutic Option for Treatment of Pulmonary Hypertension due to the Potent Anti-Proliferative and Vasorelaxant Properties
por: Luitel, Himal, et al.
Publicado: (2020)

Pulmonary Hypertension in Acute and Chronic High Altitude Maladaptation Disorders
por: Sydykov, Akylbek, et al.
Publicado: (2021)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

Inflammatory Mediators Drive Adverse Right Ventricular Remodeling and Dysfunction and Serve as Potential Biomarkers
por: Sydykov, Akylbek, et al.
Publicado: (2018)

An Exaggerated Rise in Pulmonary Artery Pressure in a High-Altitude Dweller during the Cold Season
por: Sydykov, Akylbek, et al.
Publicado: (2021)

What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)

Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

Animal Coronaviruses and SARS-COV-2 in Animals, What Do We Actually Know?
por: Bonilauri, Paolo, et al.
Publicado: (2021)

What do we actually know about exosomal microRNAs in kidney diseases?
por: Li, Qianyu, et al.
Publicado: (2022)

“What We Know and What We Do Not Know about Evolutionary Genetic Adaptation to High Altitude Hypoxia in Andean Aymaras”
por: Amaru, Ricardo, et al.
Publicado: (2023)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

Enhanced circulating levels of CD3 cells-derived extracellular vesicles in different forms of pulmonary hypertension
por: Kosanovic, Djuro, et al.
Publicado: (2019)

What we actually know about the pathogenicity of Bacteroides pyogenes
por: Majewska, Anna, et al.
Publicado: (2021)

Isolated Nocturnal Hypertension: What Do We Know and What Can We Do?
por: Tadic, Marijana, et al.
Publicado: (2020)

Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Osterholm, Michael T., et al.
Publicado: (2015)

Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)

Gynecologists and pelvic inflammatory disease: do we actually know what to do?: A cross-sectional study in Jordan
por: Al-Kuran, Oqba Al, et al.
Publicado: (2023)

Cerebrospinal fluid circulation: What do we know and how do we know it?
por: Khasawneh, Ahmad H, et al.
Publicado: (2018)

Metal wear particles: What we know, what we do not know, and why
por: Billi, Fabrizio, et al.
Publicado: (2009)

Mechanisms of atrial fibrillation in athletes: what we know and what we do not know
por: Guasch, E., et al.
Publicado: (2018)

Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
por: Rai, Mahendra, et al.
Publicado: (2021)

Ticks and Tularemia: Do We Know What We Don't Know?
por: Zellner, Briana, et al.
Publicado: (2019)

Cardiac surgery and the coronavirus disease 2019 pandemic: What we know, what we do not know, and what we need to do
por: Bakaeen, Faisal G., et al.
Publicado: (2020)

Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?
por: Gershman, Boris, et al.
Publicado: (2015)

Thymic neuroendocrine neoplasms—what we know, what we don’t know, and what to do about it
por: Lang, Matthias, et al.
Publicado: (2023)

What patients want to know, and what we actually tell them: The ABIDE project
por: Fruijtier, Agnetha D., et al.
Publicado: (2020)

Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know
por: Sun, Chuan-bin, et al.
Publicado: (2020)

The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know
por: Goldstein, David S.
Publicado: (2021)

Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

The risk of viral transmission in feed: What do we know, what do we do?
por: Dee, Scott A., et al.
Publicado: (2020)

Experimental subjects do not know what we think they know
por: Field, Jared M., et al.
Publicado: (2020)

Health Statistics in Australia: What We Know and Do Not Know
por: Madden, Richard, et al.
Publicado: (2022)

Equine Crofton Weed (Ageratina spp.) Pneumotoxicity: What Do We Know and What Do We Need to Know?
por: Shapter, Frances Marie, et al.
Publicado: (2023)

The cancer-obesity connection: what do we know and what can we do?
por: Riboli, Elio
Publicado: (2014)

Multinational monkeypox outbreak: what do we know and what should we do?
por: Memariani, Mojtaba, et al.
Publicado: (2022)

Sodium and brain injury: do we know what we are doing?
por: Zygun, David A
Publicado: (2009)

Post orgasmic illness syndrome: what do we know till now?
por: Abdessater, Maher, et al.
Publicado: (2019)

COVID-19 and cancer: do we really know what we think we know?
por: Robinson, Andrew G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_khl44aqg84kala5ucktm6e9irm